AcelRx Pharmaceuticals Cash from Operations TTM:
-24.58M for Dec. 31, 2012AcelRx Pharmaceuticals Historical Cash from Operations TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -24.58M |
| Sept. 30, 2012 | -24.77M |
| June 30, 2012 | -22.36M |
| March 31, 2012 | -21.67M |
| Dec. 31, 2011 | -15.29M |
| Sept. 30, 2011 | -12.48M |
| June 30, 2011 | -10.61M |
| March 31, 2011 | -10.05M |
| Dec. 31, 2010 | -12.22M |
About Cash From Operations (TTM)
ACRX Cash from Operations TTM Benchmarks
| Companies | |
|---|---|
| Astex Pharmaceuticals | 18.02M |
| Cyanotech Corporation | 2.199M |
| Intercept Pharmaceuticals |
ACRX Cash from Operations TTM Rankings
| Overall |
39th percentile 4830 of 8002 |
| Sector |
25th percentile 511 of 684 in Healthcare |
| Industry |
29th percentile 38 of 54 in Drug Manufacturers - Major |
ACRX Cash from Operations TTM Range, Past 5 Years
| Minimum | -24.77M | Sep 2012 |
| Maximum | -10.05M | Mar 2011 |
| Average | -17.12M |
ACRX News
AcelRx Pharma (ACRX) Stock Higher; Sufentanil NanoTab Study Meets Primary Endpoint
Street Insider 7:56 AM
Street Insider 7:56 AM
AcelRx Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 8
Seeking Alpha May 8